<DOC>
	<DOCNO>NCT00004799</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare safety efficacy acellular 2-component vs. acellular multicomponent vs. whole-cell pertussis vaccine vs. placebo infant live Sweden . II . Compare relative protection vaccine atypical subclinical pertussis infection . III . Analyze possible laboratory correlate vaccine protection .</brief_summary>
	<brief_title>Phase III Randomized , Double-Blind , Placebo-Controlled Study Acellular Whole-Cell Pertussis Vaccines</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double-blind study . Patients stratify participate institution . The first group infants receive vaccine compose inactivated pertussis toxin ( iPT ) filamentous hemagglutin ( FHA ) . The second group receive vaccine contain iPT , FHA , pertactin , agglutinogen 2 , agglutinogen 3 . The third group receive whole-cell pertussis vaccine . The fourth group receive diphtheria-tetanus vaccine control . All vaccine give intramuscular injection , 2-3 , 4 , 6 month age . Close surveillance infant family continue 2-3 year .</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Population Characteristics Infants age 2 month plan date first vaccination No prior pertussis confirm culture The following exclude : Down syndrome Prematurity Healthy baby vaccinate accord chronological age Recent pertussis exposure Seizures parent sibling Sudden infant death sibling Close relative history anaphylaxis allergy Close relative history strong reaction vaccination Patient Characteristics Age : Under 3 month Renal : No renal failure Other : No prior gammaglobulin No requirement immunosuppressive , e.g. , HIV infection No manifest immunosuppression No serious chronic illness associate failure thrive No cardiac disease No progressive neurologic disease No uncontrolled epilepsy infantile spasm No parental language communication barrier</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>January 1997</verification_date>
	<keyword>bacterial infection</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>pertussis</keyword>
	<keyword>rare disease</keyword>
</DOC>